Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $108,828 | 24 | 98.5% |
| Travel and Lodging | $1,237 | 2 | 1.1% |
| Food and Beverage | $391.24 | 5 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TARO PHARMACEUTICALS USA, INC. | $80,559 | 9 | $0 (2017) |
| Bausch Health US, LLC | $27,322 | 4 | $0 (2018) |
| Roche Products Limited | $1,536 | 3 | $0 (2017) |
| AbbVie, Inc. | $947.76 | 11 | $0 (2019) |
| Myriad Genetic Laboratories, Inc. | $41.11 | 2 | $0 (2023) |
| Genentech USA, Inc. | $36.94 | 1 | $0 (2024) |
| Hologic Sales and Service, LLC | $13.93 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50.87 | 2 | Genentech USA, Inc. ($36.94) |
| 2023 | $41.11 | 2 | Myriad Genetic Laboratories, Inc. ($41.11) |
| 2019 | $947.76 | 11 | AbbVie, Inc. ($947.76) |
| 2018 | $27,322 | 4 | Bausch Health US, LLC ($27,322) |
| 2017 | $82,095 | 12 | TARO PHARMACEUTICALS USA, INC. ($80,559) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/25/2024 | Hologic Sales and Service, LLC | Localizer (Device) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Breast and Skeletal Health | ||||||
| 01/18/2024 | Genentech USA, Inc. | Phesgo (Biological) | Food and Beverage | In-kind items and services | $36.94 | General |
| Category: BioOncology | ||||||
| 10/11/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $34.22 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 07/17/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $25.00 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 07/17/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $7.14 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 04/05/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $335.96 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 04/05/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $64.00 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 04/05/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $58.57 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 04/05/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $36.06 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 04/05/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $18.86 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 04/05/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $18.75 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 04/04/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $204.06 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 04/04/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $145.14 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 07/31/2018 | Bausch Health US, LLC | — | — | Cash or cash equivalent | $6,393.75 | Research |
| Study: A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-123 LOTION AND IDP-123 VEHICLE LOTION IN THE TREATMENT OF ACNE VULGARIS | ||||||
| 05/30/2018 | Bausch Health US, LLC | — | — | Cash or cash equivalent | $4,543.75 | Research |
| Study: A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-123 LOTION AND IDP-123 VEHICLE LOTION IN THE TREATMENT OF ACNE VULGARIS | ||||||
| 05/14/2018 | Bausch Health US, LLC | — | — | Cash or cash equivalent | $12,096.25 | Research |
| Study: A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-123 LOTION AND IDP-123 VEHICLE LOTION IN THE TREATMENT OF ACNE VULGARIS | ||||||
| 04/05/2018 | Bausch Health US, LLC | — | — | Cash or cash equivalent | $4,287.75 | Research |
| Study: A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-123 LOTION AND IDP-123 VEHICLE LOTION IN THE TREATMENT OF ACNE VULGARIS | ||||||
| 11/13/2017 | TARO PHARMACEUTICALS USA, INC. | Topicort Spray 0.25% (Drug) | — | Cash or cash equivalent | $7,700.00 | Research |
| Study: TaroLCNZ 1618 • Category: Dermatology | ||||||
| 09/28/2017 | Roche Products Limited | Xolair (Biological) | Travel and Lodging | In-kind items and services | $1,003.46 | General |
| Category: Immunology | ||||||
| 09/28/2017 | Roche Products Limited | Xolair (Biological) | Food and Beverage | In-kind items and services | $299.26 | General |
| Category: Immunology | ||||||
| 09/28/2017 | Roche Products Limited | Xolair (Biological) | Travel and Lodging | In-kind items and services | $233.63 | General |
| Category: Immunology | ||||||
| 09/20/2017 | TARO PHARMACEUTICALS USA, INC. | Topicort Spray 0.25% (Drug) | — | Cash or cash equivalent | $1,800.00 | Research |
| Study: TaroLCNZ 1618 • Category: Dermatology | ||||||
| 08/20/2017 | TARO PHARMACEUTICALS USA, INC. | Topicort Spray 0.25% (Drug) | — | Cash or cash equivalent | $9,720.00 | Research |
| Study: TaroLCNZ 1618 • Category: Dermatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TaroLCNZ 1618 | TARO PHARMACEUTICALS USA, INC. | $80,559 | 9 |
| A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, 2 ARM, PARALLEL GROUP STUDY COMPARING THE SAFETY AND EFFICACY OF IDP-123 LOTION AND IDP-123 VEHICLE LOTION IN THE TREATMENT OF ACNE VULGARIS | Bausch Health US, LLC | $27,322 | 4 |
| M16-100 | AbbVie, Inc. | $947.76 | 11 |
About Dr. Frances Herbert, M.D
Dr. Frances Herbert, M.D is a Specialist healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013005982.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frances Herbert, M.D has received a total of $110,457 in payments from pharmaceutical and medical device companies, with $50.87 received in 2024. These payments were reported across 31 transactions from 7 companies. The most common payment nature is "" ($108,828).
Practice Information
- Specialty Specialist
- Other Specialties Urology
- Location Plano, TX
- Active Since 10/10/2006
- Last Updated 04/17/2012
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1013005982
Products in Payments
- Topicort Spray 0.25% (Drug) $80,559
- Xolair (Biological) $1,536
- Androgel (Drug) $947.76
- MYRISK (Device) $41.11
- Phesgo (Biological) $36.94
- Localizer (Device) $13.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Plano
F. Barber, M.d, M.D
Specialist — Payments: $362,181
Dr. Rajesh Arakal, M.d, M.D
Specialist — Payments: $100,281
Dr. Jeffrey Adelglass, M.d, M.D
Specialist — Payments: $39,291
Dr. Robert Wilcox, Md Pa, MD PA
Specialist — Payments: $25,752
Dr. Aaron Bransky, Md, MD
Specialist — Payments: $25,257
Dr. Ronald Friedman, M.d, M.D
Specialist — Payments: $21,305